FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer

Rigshospitalet, Denmark13 enrolled

Overview

The purpose of the study is to determine the value of FLT-PET early after initiated chemotherapy in patients with small cell lung cancer, and to determine whether MRI of the brain should be performed routinely in these patients.

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Small Cell Lung Cancer

Interventions

FLT-PETDEVICE

MRIDEVICE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * biopsy proven small cell lung cancer * referred for standard chemotherapy * oral and written informed consent Exclusion Criteria: * metal or electronical devices in the body not compatible with MRI of brain or thorax * pregnancy or lactation * communication difficulties

Locations (1)

Dept. of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet

Copenhagen, Denmark

Outcomes

Primary Outcomes

Overall survival

Time frame: 1 year

Disease free survival

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.